首页 > 市场调查报告书 > 医疗设备

生技设备

全球细胞分离市场、市场规模、份额和趋势：按产品、按细胞类型、按细胞来源、按技术、按应用 - 预测（截至 2029 年）

市场调查报告书

商品编码

1524086

全球细胞分离市场、市场规模、份额和趋势：按产品、按细胞类型、按细胞来源、按技术、按应用 - 预测（截至 2029 年）

Cell Isolation Market / Cell Separation Market Size, Share & Trends by Product, Cell Type, Cell Source, Technique, Application - Global Forecast to 2029

出版日期: 2024年07月26日 | 出版商:

MarketsandMarkets | 英文 476 Pages | 订单完成后即时交付

价格

简介目录图表

全球细胞分离市场规模预计将从2024年的46亿美元增加至2029年的84亿美元，2024年至2029年的复合年增长率为12.9%。

多个重要因素将有助于市场的未来成长。政府对细胞研究的支持不断增加，癌症和感染疾病的流行也增加。此外，人们越来越关注科技发展和个人化医疗。此外，新兴国家提供了重要的发展机会，并且对下一代治疗方法的日益关注预计将进一步推动市场。

调查范围
调查年份	2022-2029
基准年	2023年
预测期	2024-2029
单元	10亿美元
部分	产品、细胞类型、细胞来源、技术、应用、最终用户
目标区域	北美、欧洲、亚太地区、拉丁美洲、中东/非洲

“从应用来看，生物医学分离领域在 2023 年占据最大份额。”

细胞分离使研究人员能够专注于特定的细胞群并提取目标分子以进行进一步分析、表征和用于治疗或研究应用。生物分子分离的细胞分离市场的主要成长动力是用于治疗感染疾病和慢性病的生物製药的需求不断增加、细胞分析技术在生物分子分离中的创新和先进应用以及全球生物製药的产业成长。

“2023年，美国继续主导市场。”

美国是全球最大的生物製药市场，也是生物製药研究和投资的领导者。美国也拥有强大的医疗基础设施，支持生命科学研究和发展。此外，许多生物製药公司的大量存在以及生物技术行业研究活动的活性化也支持了美国市场的成长。此外，由于癌症盛行率的增加，人们越来越关注基于细胞的研究的发展，这也促进了细胞分离市场的成长。

本报告对全球细胞分离市场进行研究和分析，提供关键驱动和限制、竞争格局和未来趋势等资讯。

介绍
市场动态
- 促进因素
- 抑制因素
- 机会
- 任务
影响客户业务的趋势/干扰
技术分析
- 主要技术
- 互补技术
- 邻近技术
价格分析
- 主要企业平均售价趋势：依产品分类
- 产品平均售价趋势：依技术分类
- 平均销售价格趋势：按地区
价值链分析
专利分析
供应链分析
生态系分析
- 原物料供应商的角色
- 产品提供者角色
- 最终使用者角色
- 监理机构的作用
监管环境
- 监管机构、政府机构和其他组织
- 监管场景
波特五力分析
重大会议和活动（2024-2025）
主要相关利益者和采购标准
贸易分析
- HS 编码 382200 的进口资料
- HS编码382200的出口资料
投资金筹措场景
生成式人工智慧对细胞分离市场的影响

第六章细胞分离市场：副产品

介绍
消耗品
- 试剂、套件、培养基、血清
- 珠
- 免洗用品
装置
- 离心机
- 细胞分选仪
- 磁激活细胞分离系统
- 过滤系统

第七章细胞分离市场：依细胞类型

介绍
人体细胞
- 分化细胞
- 干细胞
动物细胞

第八章细胞分离市场：依细胞来源

介绍
脂肪组织
骨髓
脐带血/胚胎干细胞
其他细胞来源

第九章细胞分离市场：依技术分类

介绍
基于离心的细胞分离
基于表面标誌物的细胞分离
基于过滤的细胞分离

第10章细胞分离市场：依应用分类

介绍
生物分子的分离
癌症研究
干细胞研究
组织再生/再生医学
体外诊断
其他用途

第十一章细胞分离市场：依最终用户分类

介绍
製药公司、生技公司
学术/研究机构
医院/诊断实验室
其他最终用户

第十二章细胞分离市场：按地区

介绍
北美洲
- 经济衰退对北美的影响
- 美国
- 加拿大
欧洲
- 经济衰退对欧洲的影响
- 德国
- 英国
- 法国
- 义大利
- 西班牙
- 欧洲其他地区
亚太地区
- 经济衰退对亚太地区的影响
- 中国
- 日本
- 印度
- 澳洲
- 韩国
- 其他亚太地区
拉丁美洲
- 经济衰退对拉丁美洲的影响
- 巴西
- 墨西哥
- 其他拉丁美洲
中东
- 经济衰退对中东的影响
- GCC
- 其他中东地区
非洲

第十三章竞争格局

概述
主要企业策略/主要企业
收益分析（2021-2023）
市场占有率分析（2023）
企业评价矩阵：主要企业（2023年）
企业评估矩阵：Start-Ups/中小企业（2023）
公司评价及财务指标
品牌/产品比较
竞争场景

第十四章公司简介

主要企业
- DANAHER CORPORATION
- MERCK KGAA
- THERMO FISHER SCIENTIFIC INC.
- BD
- SARTORIUS AG
- AGILENT TECHNOLOGIES, INC.
- BIO-RAD LABORATORIES, INC.
- QIAGEN
- F. HOFFMANN-LA ROCHE LTD.
- REVVITY
- CORNING INCORPORATED
- LONZA
- BIO-TECHNE
- TERUMO CORPORATION
- MILTENYI BIOTEC
- TAKARA BIO INC.
- GENSCRIPT
- STANDARD BIOTOOLS
- ALFA LAVAL
其他公司
- PROMEGA CORPORATION
- CELL SIGNALING TECHNOLOGY, INC.
- MICAREO INC.
- APPLIED CELLS INC.
- STEMCELL TECHNOLOGIES
- CREATIVE BIOARRAY
- PROTEINTECH GROUP, INC.
- MAGBIO GENOMICS, INC.
- AKADEUM LIFE SCIENCES
- PLURISELECT LIFE SCIENCE UG (HAFTUNGSBESCHRANKT) & CO. KG
- INVENT BIOTECHNOLOGIES, INC.

第十五章附录

简介目录图表

Product Code: BT 2757

The cell isolation market is expected to grow to USD 8.4 billion by 2029, up from USD 4.6 billion in 2024, at a CAGR of 12.9% between 2024 and 2029. Several significant factors contribute to the cell isolation market's potential growth. Government support for cell-based research is increasing, as is the prevalence of cancer and infectious disorders. Furthermore, there is a growing focus on technological developments and personalized medicine. Furthermore, emerging countries provide significant development opportunities, and the increased emphasis on next-generation treatments is expected to drive the market further.

Scope of the Report
Years Considered for the Study	2022-2029
Base Year	2023
Forecast Period	2024-2029
Units Considered	Value (USD Billion)
Segments	Product, Cell Type, Cell Source, Technique, Application, and End User
Regions covered	North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

"The biomedical isolation segment accounted for the largest share of by application segment in 2023."

In 2023, the biomedical isolation segment held the largest share of the global cell isolation market by application. Cell isolation is an important process for isolating biomolecules as it allows researchers to focus on specific cell populations and extract target molecules for further analysis, characterization, and use in therapeutic or research applications. Major factors driving the growth of the cell isolation market for biomolecule isolation are the increasing demand for biopharmaceutical products for the treatment of infectious and chronic diseases, innovative and advanced applications of cell analysis techniques in biomolecule isolation, and the growth of the global biopharmaceutical industry.

"In 2023, the US remained to dominate the cell isolation market."

The US dominated the North American cell isolation market in 2023. The US is the world's largest biopharmaceutical market and the leader in biopharmaceutical research and investment. The United States also has a strong healthcare infrastructure, which encourages research and development in the life sciences. Additionally, the significant presence of many biopharmaceutical companies and growing research activities in the biotechnology industry are propelling market growth in the US. Moreover, growing focus on development of cell-based research due to growing prevalence of cancer is also driving the growth of the cell isolation market.

The primary interviews conducted for this report can be categorized as follows:

By Respondent: Supply Side- 70% and Demand Side 30%
By Designation: Managers - 45%, CXO & Directors - 30%, and Executives - 25%
By Region: North America - 40%, Europe -25%, Asia-Pacific -25%, Latin America -5% and Middle East & Africa- 5%

List of Companies Profiled in the Report:

Merck KGaA (Germany)
Danaher Corporation (US)
Thermo Fisher Scientific Inc. (US)
BD (US)
Agilent Technologies, Inc. (US)
Miltenyi Biotec (Germany)
Revvity (US)
Sartorius AG (Germany)
F. Hoffmann-La Roche Ltd. (Switzerland)
Lonza (Switzerland)
QIAGEN (Netherlands)
ALFA LAVAL (Sweden)
Terumo Corporation (Japan)
Corning Incorporated (US)
Bio-Rad Laboratories, Inc. (US)
GenScript (US)
Bio-Techne (US)
Takara Bio Inc. (Japan)
Standard BioTools (US)
Promega Corporation (US)
Cell Signaling Technology, Inc. (US)
STEMCELL Technologies (Canada)

Research Coverage:

This research report categorizes the cell isolation market by product (consumables (reagents, kits, media & sera, beads (magnetic beads and fluroscent beads), and disposables) and instruments(centrifuges, cell sorters, magnetic-activated cell seperator systems, and filtration systems)), cell type (human cells (differentiated cells and stem cells) and animal cells), cell source (adipose tissues, bone marrow, cord blood/ embryonic stem cells, and others), technique (centrifugation-based cell isolation, surface-based cell isolation, and filtration-based cell isolation), application (biomolecule isolation, cancer research, stem cell research, tissue regeneration & regenerative medicine, in-vitro diagnostics, and others), end user (pharmaceutical & biotechnology companies, academic & research institutes, hospitals & diagnostic laboratories, and other end users), and by region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the cell isolation market. A thorough analysis of the key industry players has been done to provide insights into their business overview, products, key strategies, collaborations, partnerships, and agreements. Also, it includes new product launches, collaborations and acquisitions, and recent developments associated with the cell isolation market.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing the closest approximations of the revenue numbers for the overall cell isolation market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to position their business better and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

Analysis of key drivers (surge in cases of cancer and infectious diseases and growing emphasis on technological advancements), restraints (ethical & safety issues and high cost of cell-based research), opportunities (growing focus on next generation sequencing), and Challenges (technical complexities and standardization issues) influencing the growth of the market.
Product Development/Innovation: Detailed insights on newly launched products of the cell isolation market
Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.
Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the cell isolation market
Competitive Assessment: . Merck KGaA (Germany), Danaher Corporation (US), Thermo Fisher Scientific Inc. (US), BD (US), Agilent Technologies, Inc. (US), Miltenyi Biotec (Germany), Revvity (US), Sartorius AG (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Lonza (Switzerland), QIAGEN (Netherlands), ALFA LAVAL (Sweden), Terumo Corporation (Japan), Corning Incorporated (US), Bio-Rad Laboratories, Inc. (US), GenScript (US), Bio-Techne (US), Takara Bio Inc. (Japan), Standard BioTools (US), Promega Corporation (US), Cell Signaling Technology, Inc. (US), and STEMCELL Technologies (Canada), among others in the market.

1 INTRODUCTION

1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
- 1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 STUDY SCOPE
- 1.3.1 SEGMENTS COVERED
- 1.3.2 REGIONS COVERED
- 1.3.3 YEARS CONSIDERED
- 1.3.4 CURRENCY CONSIDERED
  - 1.3.4.1 Value unit
  - 1.3.4.2 Volume unit
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
1.6 RECESSION IMPACT

2 RESEARCH METHODOLOGY

2.1 RESEARCH DATA
- 2.1.1 SECONDARY DATA
- 2.1.2 PRIMARY DATA
2.2 MARKET SIZE ESTIMATION METHODOLOGY
- 2.2.1 BOTTOM-UP APPROACH
- 2.2.2 TOP-DOWN APPROACH
2.3 GROWTH RATE PROJECTIONS
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5 RESEARCH ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
2.7 RISK ANALYSIS
2.8 RECESSION IMPACT ANALYSIS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 CELL ISOLATION MARKET OVERVIEW
4.2 NORTH AMERICAN CELL ISOLATION MARKET, BY TYPE AND COUNTRY
4.3 CELL ISOLATION MARKET SHARE, BY APPLICATION
4.4 CELL ISOLATION MARKET SHARE, BY END USER
4.5 CELL ISOLATION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

5 MARKET OVERVIEW

5.1 INTRODUCTION
5.2 MARKET DYNAMICS
- 5.2.1 DRIVERS
  - 5.2.1.1 Increasing government funding for cell-based research
  - 5.2.1.2 Surge in cases of cancer and infectious diseases
  - 5.2.1.3 Rising emphasis on technological advancements and product developments
  - 5.2.1.4 Growing focus on personalized medicine
- 5.2.2 RESTRAINTS
  - 5.2.2.1 Ethical and safety issues
  - 5.2.2.2 High cost of cell-based research
- 5.2.3 OPPORTUNITIES
  - 5.2.3.1 Growth opportunities in emerging economies
  - 5.2.3.2 Increasing focus on next-generation therapeutics
- 5.2.4 CHALLENGES
  - 5.2.4.1 Complex development process of cell therapies
  - 5.2.4.2 Technical complexities and stringent regulatory requirements
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
5.4 TECHNOLOGY ANALYSIS
- 5.4.1 KEY TECHNOLOGIES
  - 5.4.1.1 Centrifugation-based techniques
  - 5.4.1.2 Magnetic cell isolation
  - 5.4.1.3 Fluorescence-activated cell sorting
  - 5.4.1.4 Acoustic cell isolation
  - 5.4.1.5 Acoustofluidic cell isolation
  - 5.4.1.6 Microfiltration
- 5.4.2 COMPLEMENTARY TECHNOLOGIES
  - 5.4.2.1 Mass cytometry
  - 5.4.2.2 Cell imaging technologies
  - 5.4.2.3 Artificial intelligence and machine learning
- 5.4.3 ADJACENT TECHNOLOGIES
  - 5.4.3.1 Single-cell sequencing
  - 5.4.3.2 Clustered regularly interspaced short palindromic repeats and gene editing
  - 5.4.3.3 3D cell culture
5.5 PRICING ANALYSIS
- 5.5.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT
- 5.5.2 AVERAGE SELLING PRICE TREND OF PRODUCTS, BY TECHNIQUE
- 5.5.3 AVERAGE SELLING PRICE TREND, BY REGION
5.6 VALUE CHAIN ANALYSIS
5.7 PATENT ANALYSIS
5.8 SUPPLY CHAIN ANALYSIS
5.9 ECOSYSTEM ANALYSIS
- 5.9.1 ROLE OF RAW MATERIAL VENDORS
- 5.9.2 ROLE OF PRODUCT PROVIDERS
- 5.9.3 ROLE OF END USERS
- 5.9.4 ROLE OF REGULATORY AUTHORITIES
5.10 REGULATORY LANDSCAPE
- 5.10.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 5.10.2 REGULATORY SCENARIO
5.11 PORTER'S FIVE FORCES ANALYSIS
- 5.11.1 THREAT OF NEW ENTRANTS
- 5.11.2 THREAT OF SUBSTITUTES
- 5.11.3 BARGAINING POWER OF SUPPLIERS
- 5.11.4 BARGAINING POWER OF BUYERS
- 5.11.5 INTENSITY OF COMPETITIVE RIVALRY
5.12 KEY CONFERENCES AND EVENTS, 2024-2025
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
- 5.13.1 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS
- 5.13.2 BUYING CRITERIA
5.14 TRADE ANALYSIS
- 5.14.1 IMPORT DATA FOR HS CODE 382200
- 5.14.2 EXPORT DATA FOR HS CODE 382200
5.15 INVESTMENT AND FUNDING SCENARIO
5.16 IMPACT OF GENERATIVE AI ON CELL ISOLATION MARKET

6 CELL ISOLATION MARKET, BY PRODUCT

6.1 INTRODUCTION
6.2 CONSUMABLES
- 6.2.1 REAGENTS, KITS, MEDIA, AND SERA
  - 6.2.1.1 Surge in product launches and repetitive purchases to boost segment growth
- 6.2.2 BEADS
  - 6.2.2.1 Magnetic beads
    - 6.2.2.1.1 Growing demand in biomedical research and clinical applications to drive market
  - 6.2.2.2 Fluorescent beads
    - 6.2.2.2.1 Increasing use in flow cytometry, cell sorting, and imaging applications to fuel market
- 6.2.3 DISPOSABLES
  - 6.2.3.1 Growing government investments in research to aid market growth
6.3 INSTRUMENTS
- 6.3.1 CENTRIFUGES
  - 6.3.1.1 Growing use in pharma-biotech industry to boost market
- 6.3.2 CELL SORTERS
  - 6.3.2.1 Rise in cell-based research initiatives to augment growth
- 6.3.3 MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS
  - 6.3.3.1 Booming use in research for T-cell and stem cell isolation to drive market
- 6.3.4 FILTRATION SYSTEMS
  - 6.3.4.1 Rising need to ensure Good Manufacturing Practice standards and regulations to boost market

7 CELL ISOLATION MARKET, BY CELL TYPE

7.1 INTRODUCTION
7.2 HUMAN CELLS
- 7.2.1 DIFFERENTIATED CELLS
  - 7.2.1.1 Increasing use in disease modeling, regenerative medicine, and gene therapy to fuel growth
- 7.2.2 STEM CELLS
  - 7.2.2.1 Rise in grants and funding for stem cell research to drive market
7.3 ANIMAL CELLS
- 7.3.1 GROWING INVESTMENTS FOR VACCINE AND DRUG DEVELOPMENT TO SUPPORT GROWTH

8 CELL ISOLATION MARKET, BY CELL SOURCE

8.1 INTRODUCTION
8.2 ADIPOSE TISSUE
- 8.2.1 INCREASING APPLICATIONS IN CLINICAL STUDIES AND TRIALS TO DRIVE MARKET
8.3 BONE MARROW
- 8.3.1 GROWING DEMAND FOR TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS TO AID GROWTH
8.4 CORD BLOOD/EMBRYONIC STEM CELLS
- 8.4.1 HIGH THERAPEUTIC POTENCY TO SUPPORT MARKET GROWTH
8.5 OTHER CELL SOURCES

9 CELL ISOLATION MARKET, BY TECHNIQUE

9.1 INTRODUCTION
9.2 CENTRIFUGATION-BASED CELL ISOLATION
- 9.2.1 RISE IN USE BY BIOTECH AND BIOPHARMACEUTICAL COMPANIES TO FUEL MARKET
9.3 SURFACE MARKER-BASED CELL ISOLATION
- 9.3.1 INCREASING ADOPTION OF MAGNETIC-ACTIVATED CELL SORTING TO PROPEL MARKET
9.4 FILTRATION-BASED CELL ISOLATION
- 9.4.1 NEED FOR AFFORDABLE FILTRATION TECHNIQUE TO DRIVE MARKET

10 CELL ISOLATION MARKET, BY APPLICATION

10.1 INTRODUCTION
10.2 BIOMOLECULE ISOLATION
- 10.2.1 INCREASING DEMAND FOR BIOPHARMACEUTICAL PRODUCTS TO FUEL MARKET
10.3 CANCER RESEARCH
- 10.3.1 GROWING INCLINATION TOWARD DEVELOPING AND MANUFACTURING CANCER TREATMENTS TO DRIVE MARKET
10.4 STEM CELL RESEARCH
- 10.4.1 RISING GRANTS AND FUNDING FOR STEM CELL RESEARCH TO AUGMENT GROWTH
10.5 TISSUE REGENERATION & REGENERATIVE MEDICINE
- 10.5.1 GROWING INITIATIVES FOR RESEARCH IN REGENERATIVE MEDICINE TO SUPPORT MARKET
10.6 IN VITRO DIAGNOSTICS
- 10.6.1 NEED FOR ACCURACY TO IDENTIFY CELL TYPE TO PROPEL MARKET
10.7 OTHER APPLICATIONS

11 CELL ISOLATION MARKET, BY END USER

11.1 INTRODUCTION
11.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
- 11.2.1 INCREASING INVESTMENTS BY KEY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO BOOST MARKET GROWTH
11.3 ACADEMIC & RESEARCH INSTITUTES
- 11.3.1 HIGH GOVERNMENT FUNDING FOR EDUCATIONAL PURPOSES TO FUEL SEGMENT
11.4 HOSPITALS & DIAGNOSTIC LABORATORIES
- 11.4.1 INCREASING NUMBER OF HEALTHCARE FACILITIES IN EMERGING ECONOMIES TO DRIVE MARKET
11.5 OTHER END USERS

12 CELL ISOLATION MARKET, BY REGION

12.1 INTRODUCTION
12.2 NORTH AMERICA
- 12.2.1 NORTH AMERICA: RECESSION IMPACT
- 12.2.2 US
  - 12.2.2.1 Rising prevalence of cancer to drive market
- 12.2.3 CANADA
  - 12.2.3.1 Increased government funding for stem cell and vaccine research to propel market
12.3 EUROPE
- 12.3.1 EUROPE: RECESSION IMPACT
- 12.3.2 GERMANY
  - 12.3.2.1 Rising interest in biotechnology drugs and applications to aid market growth
- 12.3.3 UK
  - 12.3.3.1 Increasing prevalence of infectious diseases to drive market
- 12.3.4 FRANCE
  - 12.3.4.1 Surge in investments in cell biology research activities to drive market
- 12.3.5 ITALY
  - 12.3.5.1 Rising number of cell biology seminars and conferences to drive market
- 12.3.6 SPAIN
  - 12.3.6.1 Increasing funding from private and public organizations to aid growth
- 12.3.7 REST OF EUROPE
12.4 ASIA PACIFIC
- 12.4.1 ASIA PACIFIC: RECESSION IMPACT
- 12.4.2 CHINA
  - 12.4.2.1 Increasing investments in research and technological advancements to boost market
- 12.4.3 JAPAN
  - 12.4.3.1 Dominant geriatric population to aid market growth
- 12.4.4 INDIA
  - 12.4.4.1 Growing penetration of healthcare insurance services to propel market
- 12.4.5 AUSTRALIA
  - 12.4.5.1 Growing emphasis on personalized medicine, biopharmaceuticals, and advanced therapies to fuel market
- 12.4.6 SOUTH KOREA
  - 12.4.6.1 Rising need for therapeutics to support market growth
- 12.4.7 REST OF ASIA PACIFIC
12.5 LATIN AMERICA
- 12.5.1 LATIN AMERICA: RECESSION IMPACT
- 12.5.2 BRAZIL
  - 12.5.2.1 Need to improve public access to modern healthcare facilities to drive market
- 12.5.3 MEXICO
  - 12.5.3.1 Favorable trade agreements to support market
- 12.5.4 REST OF LATIN AMERICA
12.6 MIDDLE EAST
- 12.6.1 MIDDLE EAST: RECESSION IMPACT
- 12.6.2 GCC
  - 12.6.2.1 Saudi Arabia
    - 12.6.2.1.1 Growing focus on Vision 2030 initiatives to boost market
  - 12.6.2.2 UAE
    - 12.6.2.2.1 Rising inclination toward producing high-value specialty drugs to aid market growth
  - 12.6.2.3 Rest of GCC Countries
- 12.6.3 REST OF MIDDLE EAST
12.7 AFRICA
- 12.7.1 INCREASING PATIENT POPULATION WITH CANCER TO PROPEL MARKET
- 12.7.2 AFRICA: RECESSION IMPACT

13 COMPETITIVE LANDSCAPE

13.1 OVERVIEW
13.2 KEY PLAYER STRATEGY/RIGHT TO WIN
- 13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN CELL ISOLATION MARKET
13.3 REVENUE ANALYSIS, 2021-2023
13.4 MARKET SHARE ANALYSIS, 2023
13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
- 13.5.1 STARS
- 13.5.2 EMERGING LEADERS
- 13.5.3 PERVASIVE PLAYERS
- 13.5.4 PARTICIPANTS
- 13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
  - 13.5.5.1 Company footprint
  - 13.5.5.2 Region footprint
  - 13.5.5.3 Type footprint
  - 13.5.5.4 Cell type footprint
  - 13.5.5.5 End user footprint
13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
- 13.6.1 PROGRESSIVE COMPANIES
- 13.6.2 RESPONSIVE COMPANIES
- 13.6.3 DYNAMIC COMPANIES
- 13.6.4 STARTING BLOCKS
- 13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
13.7 COMPANY VALUATION AND FINANCIAL METRICS
13.8 BRAND/PRODUCT COMPARISON
13.9 COMPETITIVE SCENARIO
- 13.9.1 PRODUCT LAUNCHES
- 13.9.2 DEALS
- 13.9.3 EXPANSIONS
- 13.9.4 OTHER DEVELOPMENTS

14 COMPANY PROFILES

14.1 KEY PLAYERS
- 14.1.1 DANAHER CORPORATION
  - 14.1.1.1 Business overview
  - 14.1.1.2 Products offered
  - 14.1.1.3 Recent developments
    - 14.1.1.3.1 Deals
  - 14.1.1.4 MnM view
    - 14.1.1.4.1 Key strengths
    - 14.1.1.4.2 Strategic choices
    - 14.1.1.4.3 Weaknesses and competitive threats
- 14.1.2 MERCK KGAA
  - 14.1.2.1 Business overview
  - 14.1.2.2 Products offered
  - 14.1.2.3 Recent developments
    - 14.1.2.3.1 Deals
    - 14.1.2.3.2 Expansions
  - 14.1.2.4 MnM view
    - 14.1.2.4.1 Key strengths
    - 14.1.2.4.2 Strategic choices
    - 14.1.2.4.3 Weaknesses and competitive threats
- 14.1.3 THERMO FISHER SCIENTIFIC INC.
  - 14.1.3.1 Business overview
  - 14.1.3.2 Products offered
  - 14.1.3.3 Recent developments
    - 14.1.3.3.1 Product launches
    - 14.1.3.3.2 Deals
    - 14.1.3.3.3 Expansions
  - 14.1.3.4 MnM view
    - 14.1.3.4.1 Key strengths
    - 14.1.3.4.2 Strategic choices
    - 14.1.3.4.3 Weaknesses and competitive threats
- 14.1.4 BD
  - 14.1.4.1 Business overview
  - 14.1.4.2 Products offered
  - 14.1.4.3 Recent developments
    - 14.1.4.3.1 Product launches
    - 14.1.4.3.2 Deals
    - 14.1.4.3.3 Other developments
- 14.1.5 SARTORIUS AG
  - 14.1.5.1 Business overview
  - 14.1.5.2 Products offered
  - 14.1.5.3 Recent developments
    - 14.1.5.3.1 Deals
- 14.1.6 AGILENT TECHNOLOGIES, INC.
  - 14.1.6.1 Business overview
  - 14.1.6.2 Products offered
  - 14.1.6.3 Recent developments
    - 14.1.6.3.1 Deals
- 14.1.7 BIO-RAD LABORATORIES, INC.
  - 14.1.7.1 Business overview
  - 14.1.7.2 Products offered
  - 14.1.7.3 Recent developments
    - 14.1.7.3.1 Product launches
- 14.1.8 QIAGEN
  - 14.1.8.1 Business overview
  - 14.1.8.2 Products offered
  - 14.1.8.3 Recent developments
    - 14.1.8.3.1 Deals
- 14.1.9 F. HOFFMANN-LA ROCHE LTD.
  - 14.1.9.1 Business overview
  - 14.1.9.2 Products offered
- 14.1.10 REVVITY
  - 14.1.10.1 Business overview
  - 14.1.10.2 Products offered
  - 14.1.10.3 Recent developments
    - 14.1.10.3.1 Other developments
- 14.1.11 CORNING INCORPORATED
  - 14.1.11.1 Business overview
  - 14.1.11.2 Products offered
- 14.1.12 LONZA
  - 14.1.12.1 Business overview
  - 14.1.12.2 Products offered
  - 14.1.12.3 Recent developments
    - 14.1.12.3.1 Product launches
    - 14.1.12.3.2 Deals
- 14.1.13 BIO-TECHNE
  - 14.1.13.1 Business overview
  - 14.1.13.2 Products offered
  - 14.1.13.3 Recent developments
    - 14.1.13.3.1 Deals
    - 14.1.13.3.2 Other developments
- 14.1.14 TERUMO CORPORATION
  - 14.1.14.1 Business overview
  - 14.1.14.2 Products offered
  - 14.1.14.3 Recent developments
    - 14.1.14.3.1 Deals
- 14.1.15 MILTENYI BIOTEC
  - 14.1.15.1 Business overview
  - 14.1.15.2 Products offered
- 14.1.16 TAKARA BIO INC.
  - 14.1.16.1 Business overview
  - 14.1.16.2 Products offered
  - 14.1.16.3 Recent developments
    - 14.1.16.3.1 Deals
- 14.1.17 GENSCRIPT
  - 14.1.17.1 Business overview
  - 14.1.17.2 Products offered
  - 14.1.17.3 Recent developments
    - 14.1.17.3.1 Deals
- 14.1.18 STANDARD BIOTOOLS
  - 14.1.18.1 Business overview
  - 14.1.18.2 Products offered
- 14.1.19 ALFA LAVAL
  - 14.1.19.1 Business overview
  - 14.1.19.2 Products offered
  - 14.1.19.3 Recent developments
    - 14.1.19.3.1 Product launches
    - 14.1.19.3.2 Deals
14.2 OTHER PLAYERS
- 14.2.1 PROMEGA CORPORATION
- 14.2.2 CELL SIGNALING TECHNOLOGY, INC.
- 14.2.3 MICAREO INC.
- 14.2.4 APPLIED CELLS INC.
- 14.2.5 STEMCELL TECHNOLOGIES
- 14.2.6 CREATIVE BIOARRAY
- 14.2.7 PROTEINTECH GROUP, INC.
- 14.2.8 MAGBIO GENOMICS, INC.
- 14.2.9 AKADEUM LIFE SCIENCES
- 14.2.10 PLURISELECT LIFE SCIENCE UG (HAFTUNGSBESCHRANKT) & CO. KG
- 14.2.11 INVENT BIOTECHNOLOGIES, INC.

15 APPENDIX

15.1 DISCUSSION GUIDE
15.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
15.3 CUSTOMIZATION OPTIONS
15.4 RELATED REPORTS
15.5 AUTHOR DETAILS

简介目录图表

List of Tables

TABLE 1 CELL ISOLATION MARKET: INCLUSIONS AND EXCLUSIONS
TABLE 2 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
TABLE 3 IMPACT ANALYSIS OF MARKET DYNAMICS
TABLE 4 NATIONAL INSTITUTES OF HEALTH FUNDING FOR CELL-BASED RESEARCH, 2019-2025 (USD MILLION)
TABLE 5 CANCER INCIDENCE WORLDWIDE, 2020 VS. 2040
TABLE 6 FDA APPROVAL RATE FOR PERSONALIZED MEDICINES, 2015-2022
TABLE 7 INVESTMENT ROUNDS IN ASIA PACIFIC BIOTECH COMPANIES, 2023
TABLE 8 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT, 2021-2023 (USD)
TABLE 9 AVERAGE SELLING PRICE TREND, BY REGION, 2021-2023 (USD)
TABLE 10 INNOVATIONS AND PATENT REGISTRATIONS, 2023-2024
TABLE 11 CELL ISOLATION MARKET: ROLE OF RAW MATERIAL VENDORS IN ECOSYSTEM
TABLE 12 CELL ISOLATION MARKET: ROLE OF PRODUCT PROVIDERS IN ECOSYSTEM
TABLE 13 CELL ISOLATION MARKET: ROLE OF END USERS IN ECOSYSTEM
TABLE 14 CELL ISOLATION MARKET: ROLE OF REGULATORY AUTHORITIES IN ECOSYSTEM
TABLE 15 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 16 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 17 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 18 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 19 REGULATORY GUIDELINES
TABLE 20 IMPACT OF PORTER'S FIVE FORCES
TABLE 21 KEY CONFERENCES AND EVENTS, 2024-2025
TABLE 22 BUYING CRITERIA, BY END USER
TABLE 23 IMPORT VALUE FOR HS CODE 382200 (TOP 20 COUNTRIES), 2019-2023 (USD THOUSAND)
TABLE 24 IMPORT VOLUME FOR HS CODE 382200 (TOP 20 COUNTRIES), 2019-2023 (TONS)
TABLE 25 EXPORT VALUE FOR HS CODE 382200 (TOP 20 COUNTRIES), 2019-2023 (USD THOUSAND)
TABLE 26 EXPORT VOLUME FOR HS CODE 382200 (TOP 20 COUNTRIES), 2019-2023 (TONS)
TABLE 27 CELL ISOLATION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
TABLE 28 CELL ISOLATION MARKET FOR CONSUMABLES, BY REGION, 2022-2029 (USD MILLION)
TABLE 29 NORTH AMERICA: CELL ISOLATION MARKET FOR CONSUMABLES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 30 EUROPE: CELL ISOLATION MARKET FOR CONSUMABLES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 31 ASIA PACIFIC: CELL ISOLATION MARKET FOR CONSUMABLES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 32 LATIN AMERICA: CELL ISOLATION MARKET FOR CONSUMABLES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 33 MIDDLE EAST: CELL ISOLATION MARKET FOR CONSUMABLES, BY REGION, 2022-2029 (USD MILLION)
TABLE 34 GCC COUNTRIES: CELL ISOLATION MARKET FOR CONSUMABLES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 35 CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 36 CELL ISOLATION MARKET FOR REAGENTS, KITS, MEDIA, AND SERA, BY REGION, 2022-2029 (USD MILLION)
TABLE 37 NORTH AMERICA: CELL ISOLATION MARKET FOR REAGENTS, KITS, MEDIA, AND SERA, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 38 EUROPE: CELL ISOLATION MARKET FOR REAGENTS, KITS, MEDIA, AND SERA, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 39 ASIA PACIFIC: CELL ISOLATION MARKET FOR REAGENTS, KITS, MEDIA, AND SERA, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 40 LATIN AMERICA: CELL ISOLATION MARKET FOR REAGENTS, KITS, MEDIA, AND SERA, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 41 MIDDLE EAST: CELL ISOLATION MARKET FOR REAGENTS, KITS, MEDIA, AND SERA, BY REGION, 2022-2029 (USD MILLION)
TABLE 42 GCC COUNTRIES: CELL ISOLATION MARKET FOR REAGENTS, KITS, MEDIA, AND SERA, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 43 CELL ISOLATION MARKET FOR BEADS, BY REGION, 2022-2029 (USD MILLION)
TABLE 44 NORTH AMERICA: CELL ISOLATION MARKET FOR BEADS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 45 EUROPE: CELL ISOLATION MARKET FOR BEADS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 46 ASIA PACIFIC: CELL ISOLATION MARKET FOR BEADS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 47 LATIN AMERICA: CELL ISOLATION MARKET FOR BEADS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 48 MIDDLE EAST: CELL ISOLATION MARKET FOR BEADS, BY REGION, 2022-2029 (USD MILLION)
TABLE 49 GCC COUNTRIES: CELL ISOLATION MARKET FOR BEADS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 50 CELL ISOLATION MARKET FOR BEADS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 51 CELL ISOLATION MARKET FOR MAGNETIC BEADS, BY REGION, 2022-2029 (USD MILLION)
TABLE 52 NORTH AMERICA: CELL ISOLATION MARKET FOR MAGNETIC BEADS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 53 EUROPE: CELL ISOLATION MARKET FOR MAGNETIC BEADS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 54 ASIA PACIFIC: CELL ISOLATION MARKET FOR MAGNETIC BEADS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 55 LATIN AMERICA: CELL ISOLATION MARKET FOR MAGNETIC BEADS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 56 MIDDLE EAST: CELL ISOLATION MARKET FOR MAGNETIC BEADS, BY REGION, 2022-2029 (USD MILLION)
TABLE 57 GCC COUNTRIES: CELL ISOLATION MARKET FOR MAGNETIC BEADS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 58 CELL ISOLATION MARKET FOR FLUORESCENT BEADS, BY REGION, 2022-2029 (USD MILLION)
TABLE 59 NORTH AMERICA: CELL ISOLATION MARKET FOR FLUORESCENT BEADS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 60 EUROPE: CELL ISOLATION MARKET FOR FLUORESCENT BEADS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 61 ASIA PACIFIC: CELL ISOLATION MARKET FOR FLUORESCENT BEADS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 62 LATIN AMERICA: CELL ISOLATION MARKET FOR FLUORESCENT BEADS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 63 MIDDLE EAST: CELL ISOLATION MARKET FOR FLUORESCENT BEADS, BY REGION, 2022-2029 (USD MILLION)
TABLE 64 GCC COUNTRIES: CELL ISOLATION MARKET FOR FLUORESCENT BEADS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 65 CELL ISOLATION MARKET FOR DISPOSABLES, BY REGION, 2022-2029 (USD MILLION)
TABLE 66 NORTH AMERICA: CELL ISOLATION MARKET FOR DISPOSABLES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 67 EUROPE: CELL ISOLATION MARKET FOR DISPOSABLES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 68 ASIA PACIFIC: CELL ISOLATION MARKET FOR DISPOSABLES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 69 LATIN AMERICA: CELL ISOLATION MARKET FOR DISPOSABLES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 70 MIDDLE EAST: CELL ISOLATION MARKET FOR DISPOSABLES, BY REGION, 2022-2029 (USD MILLION)
TABLE 71 GCC COUNTRIES: CELL ISOLATION MARKET FOR DISPOSABLES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 72 CELL ISOLATION MARKET FOR INSTRUMENTS, BY REGION, 2022-2029 (USD MILLION)
TABLE 73 NORTH AMERICA: CELL ISOLATION MARKET FOR INSTRUMENTS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 74 EUROPE: CELL ISOLATION MARKET FOR INSTRUMENTS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 75 ASIA PACIFIC: CELL ISOLATION MARKET FOR INSTRUMENTS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 76 LATIN AMERICA: CELL ISOLATION MARKET FOR INSTRUMENTS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 77 MIDDLE EAST: CELL ISOLATION MARKET FOR INSTRUMENTS, BY REGION, 2022-2029 (USD MILLION)
TABLE 78 GCC COUNTRIES: CELL ISOLATION MARKET FOR INSTRUMENTS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 79 CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 80 CELL ISOLATION MARKET FOR CENTRIFUGES, BY REGION, 2022-2029 (USD MILLION)
TABLE 81 NORTH AMERICA: CELL ISOLATION MARKET FOR CENTRIFUGES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 82 EUROPE: CELL ISOLATION MARKET FOR CENTRIFUGES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 83 ASIA PACIFIC: CELL ISOLATION MARKET FOR CENTRIFUGES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 84 LATIN AMERICA: CELL ISOLATION MARKET FOR CENTRIFUGES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 85 MIDDLE EAST: CELL ISOLATION MARKET FOR CENTRIFUGES, BY REGION, 2022-2029 (USD MILLION)
TABLE 86 GCC COUNTRIES: CELL ISOLATION MARKET FOR CENTRIFUGES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 87 CELL ISOLATION MARKET FOR CELL SORTERS, BY REGION, 2022-2029 (USD MILLION)
TABLE 88 NORTH AMERICA: CELL ISOLATION MARKET FOR CELL SORTERS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 89 EUROPE: CELL ISOLATION MARKET FOR CELL SORTERS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 90 ASIA PACIFIC: CELL ISOLATION MARKET FOR CELL SORTERS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 91 LATIN AMERICA: CELL ISOLATION MARKET FOR CELL SORTERS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 92 MIDDLE EAST: CELL ISOLATION MARKET FOR CELL SORTERS, BY REGION, 2022-2029 (USD MILLION)
TABLE 93 GCC COUNTRIES: CELL ISOLATION MARKET FOR CELL SORTERS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 94 CELL ISOLATION MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY REGION, 2022-2029 (USD MILLION)
TABLE 95 NORTH AMERICA: CELL ISOLATION MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 96 EUROPE: CELL ISOLATION MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 97 ASIA PACIFIC: CELL ISOLATION MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 98 LATIN AMERICA: CELL ISOLATION MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 99 MIDDLE EAST: CELL ISOLATION MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY REGION, 2022-2029 (USD MILLION)
TABLE 100 GCC COUNTRIES: CELL ISOLATION MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 101 CELL ISOLATION MARKET FOR FILTRATION SYSTEMS, BY REGION, 2022-2029 (USD MILLION)
TABLE 102 NORTH AMERICA: CELL ISOLATION MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 103 EUROPE: CELL ISOLATION MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 104 ASIA PACIFIC: CELL ISOLATION MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 105 LATIN AMERICA: CELL ISOLATION MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 106 MIDDLE EAST: CELL ISOLATION MARKET FOR FILTRATION SYSTEMS, BY REGION, 2022-2029 (USD MILLION)
TABLE 107 GCC COUNTRIES: CELL ISOLATION MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 108 CELL ISOLATION MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
TABLE 109 CELL ISOLATION MARKET FOR HUMAN CELLS, BY REGION, 2022-2029 (USD MILLION)
TABLE 110 NORTH AMERICA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 111 EUROPE: CELL ISOLATION MARKET FOR HUMAN CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 112 ASIA PACIFIC: CELL ISOLATION MARKET FOR HUMAN CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 113 LATIN AMERICA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 114 MIDDLE EAST: CELL ISOLATION MARKET FOR HUMAN CELLS, BY REGION, 2022-2029 (USD MILLION)
TABLE 115 GCC COUNTRIES: CELL ISOLATION MARKET FOR HUMAN CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 116 CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 117 CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS, BY REGION, 2022-2029 (USD MILLION)
TABLE 118 NORTH AMERICA: CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 119 EUROPE: CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 120 ASIA PACIFIC: CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 121 LATIN AMERICA: CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 122 MIDDLE EAST: CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS, BY REGION, 2022-2029 (USD MILLION)
TABLE 123 GCC COUNTRIES: CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 124 CELL ISOLATION MARKET FOR STEM CELLS, BY REGION, 2022-2029 (USD MILLION)
TABLE 125 NORTH AMERICA: CELL ISOLATION MARKET FOR STEM CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 126 EUROPE: CELL ISOLATION MARKET FOR STEM CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 127 ASIA PACIFIC: CELL ISOLATION MARKET FOR STEM CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 128 LATIN AMERICA: CELL ISOLATION MARKET FOR STEM CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 129 MIDDLE EAST: CELL ISOLATION MARKET FOR STEM CELLS, BY REGION, 2022-2029 (USD MILLION)
TABLE 130 GCC COUNTRIES: CELL ISOLATION MARKET FOR STEM CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 131 CELL ISOLATION MARKET FOR ANIMAL CELLS, BY REGION, 2022-2029 (USD MILLION)
TABLE 132 NORTH AMERICA: CELL ISOLATION MARKET FOR ANIMAL CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 133 EUROPE: CELL ISOLATION MARKET FOR ANIMAL CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 134 ASIA PACIFIC: CELL ISOLATION MARKET FOR ANIMAL CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 135 LATIN AMERICA: CELL ISOLATION MARKET FOR ANIMAL CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 136 MIDDLE EAST: CELL ISOLATION MARKET FOR ANIMAL CELLS, BY REGION, 2022-2029 (USD MILLION)
TABLE 137 GCC COUNTRIES: CELL ISOLATION MARKET FOR ANIMAL CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 138 CELL ISOLATION MARKET, BY CELL SOURCE, 2022-2029 (USD MILLION)
TABLE 139 CELL ISOLATION MARKET FOR ADIPOSE TISSUE, BY REGION, 2022-2029 (USD MILLION)
TABLE 140 NORTH AMERICA: CELL ISOLATION MARKET FOR ADIPOSE TISSUE, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 141 EUROPE: CELL ISOLATION MARKET FOR ADIPOSE TISSUE, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 142 ASIA PACIFIC: CELL ISOLATION MARKET FOR ADIPOSE TISSUE, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 143 LATIN AMERICA: CELL ISOLATION MARKET FOR ADIPOSE TISSUE, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 144 MIDDLE EAST: CELL ISOLATION MARKET FOR ADIPOSE TISSUE, BY REGION, 2022-2029 (USD MILLION)
TABLE 145 GCC COUNTRIES: CELL ISOLATION MARKET FOR ADIPOSE TISSUE, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 146 CELL ISOLATION MARKET FOR BONE MARROW, BY REGION, 2022-2029 (USD MILLION)
TABLE 147 NORTH AMERICA: CELL ISOLATION MARKET FOR BONE MARROW, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 148 EUROPE: CELL ISOLATION MARKET FOR BONE MARROW, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 149 ASIA PACIFIC: CELL ISOLATION MARKET FOR BONE MARROW, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 150 LATIN AMERICA: CELL ISOLATION MARKET FOR BONE MARROW, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 151 MIDDLE EAST: CELL ISOLATION MARKET FOR BONE MARROW, BY REGION, 2022-2029 (USD MILLION)
TABLE 152 GCC COUNTRIES: CELL ISOLATION MARKET FOR BONE MARROW, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 153 CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY REGION, 2022-2029 (USD MILLION)
TABLE 154 NORTH AMERICA: CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 155 EUROPE: CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 156 ASIA PACIFIC: CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 157 LATIN AMERICA: CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 158 MIDDLE EAST: CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY REGION, 2022-2029 (USD MILLION)
TABLE 159 GCC COUNTRIES: CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 160 CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY REGION, 2022-2029 (USD MILLION)
TABLE 161 NORTH AMERICA: CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 162 EUROPE: CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 163 ASIA PACIFIC: CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 164 LATIN AMERICA: CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 165 MIDDLE EAST: CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY REGION, 2022-2029 (USD MILLION)
TABLE 166 GCC COUNTRIES: CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 167 CELL ISOLATION MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
TABLE 168 CELL ISOLATION MARKET FOR CENTRIFUGATION-BASED CELL ISOLATION, BY REGION, 2022-2029 (USD MILLION)
TABLE 169 NORTH AMERICA: CELL ISOLATION MARKET FOR CENTRIFUGATION-BASED CELL ISOLATION, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 170 EUROPE: CELL ISOLATION MARKET FOR CENTRIFUGATION-BASED CELL ISOLATION, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 171 ASIA PACIFIC: CELL ISOLATION MARKET FOR CENTRIFUGATION-BASED CELL ISOLATION, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 172 LATIN AMERICA: CELL ISOLATION MARKET FOR CENTRIFUGATION-BASED CELL ISOLATION, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 173 MIDDLE EAST: CELL ISOLATION MARKET FOR CENTRIFUGATION-BASED CELL ISOLATION, BY REGION, 2022-2029 (USD MILLION)
TABLE 174 GCC COUNTRIES: CELL ISOLATION MARKET FOR CENTRIFUGATION-BASED CELL ISOLATION, BY REGION, 2022-2029 (USD MILLION)
TABLE 175 CELL ISOLATION MARKET FOR SURFACE MARKER-BASED CELL ISOLATION, BY REGION, 2022-2029 (USD MILLION)
TABLE 176 NORTH AMERICA: CELL ISOLATION MARKET FOR SURFACE MARKER-BASED CELL ISOLATION, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 177 EUROPE: CELL ISOLATION MARKET FOR SURFACE MARKER-BASED CELL ISOLATION, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 178 ASIA PACIFIC: CELL ISOLATION MARKET FOR SURFACE MARKER-BASED CELL ISOLATION, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 179 LATIN AMERICA: CELL ISOLATION MARKET FOR SURFACE MARKER-BASED CELL ISOLATION, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 180 MIDDLE EAST: CELL ISOLATION MARKET FOR SURFACE MARKER-BASED CELL ISOLATION, BY REGION, 2022-2029 (USD MILLION)
TABLE 181 GCC COUNTRIES: CELL ISOLATION MARKET FOR SURFACE MARKER-BASED CELL ISOLATION, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 182 CELL ISOLATION MARKET FOR FILTRATION-BASED CELL ISOLATION, BY REGION, 2022-2029 (USD MILLION)
TABLE 183 NORTH AMERICA: CELL ISOLATION MARKET FOR FILTRATION-BASED CELL ISOLATION, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 184 EUROPE: CELL ISOLATION MARKET FOR FILTRATION-BASED CELL ISOLATION, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 185 ASIA PACIFIC: CELL ISOLATION MARKET FOR FILTRATION-BASED CELL ISOLATION, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 186 LATIN AMERICA: CELL ISOLATION MARKET FOR FILTRATION-BASED CELL ISOLATION, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 187 MIDDLE EAST: CELL ISOLATION MARKET FOR FILTRATION-BASED CELL ISOLATION, BY REGION, 2022-2029 (USD MILLION)
TABLE 188 GCC COUNTRIES: CELL ISOLATION MARKET FOR FILTRATION-BASED CELL ISOLATION, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 189 CELL ISOLATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 190 CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION, BY REGION, 2022-2029 (USD MILLION)
TABLE 191 NORTH AMERICA: CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 192 EUROPE: CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 193 ASIA PACIFIC: CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 194 LATIN AMERICA: CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 195 MIDDLE EAST: CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION, BY REGION, 2022-2029 (USD MILLION)
TABLE 196 GCC COUNTRIES: CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 197 CELL ISOLATION MARKET FOR CANCER RESEARCH, BY REGION, 2022-2029 (USD MILLION)
TABLE 198 NORTH AMERICA: CELL ISOLATION MARKET FOR CANCER RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 199 EUROPE: CELL ISOLATION MARKET FOR CANCER RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 200 ASIA PACIFIC: CELL ISOLATION MARKET FOR CANCER RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 201 LATIN AMERICA: CELL ISOLATION MARKET FOR CANCER RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 202 MIDDLE EAST: CELL ISOLATION MARKET FOR CANCER RESEARCH, BY REGION, 2022-2029 (USD MILLION)
TABLE 203 GCC COUNTRIES: CELL ISOLATION MARKET FOR CANCER RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 204 CELL ISOLATION MARKET FOR STEM CELL RESEARCH, BY REGION, 2022-2029 (USD MILLION)
TABLE 205 NORTH AMERICA: CELL ISOLATION MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 206 EUROPE: CELL ISOLATION MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 207 ASIA PACIFIC: CELL ISOLATION MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 208 LATIN AMERICA: CELL ISOLATION MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 209 MIDDLE EAST: CELL ISOLATION MARKET FOR STEM CELL RESEARCH, BY REGION, 2022-2029 (USD MILLION)
TABLE 210 GCC COUNTRIES: CELL ISOLATION MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 211 CELL ISOLATION MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE, BY REGION, 2022-2029 (USD MILLION)
TABLE 212 NORTH AMERICA: CELL ISOLATION MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 213 EUROPE: CELL ISOLATION MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 214 ASIA PACIFIC: CELL ISOLATION MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 215 LATIN AMERICA: CELL ISOLATION MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 216 MIDDLE EAST: CELL ISOLATION MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE, BY REGION, 2022-2029 (USD MILLION)
TABLE 217 GCC COUNTRIES: CELL ISOLATION MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 218 CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTICS, BY REGION, 2022-2029 (USD MILLION)
TABLE 219 NORTH AMERICA: CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 220 EUROPE: CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 221 ASIA PACIFIC: CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 222 LATIN AMERICA: CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 223 MIDDLE EAST: CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTICS, BY REGION, 2022-2029 (USD MILLION)
TABLE 224 GCC COUNTRIES: CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 225 CELL ISOLATION MARKET FOR OTHER APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
TABLE 226 NORTH AMERICA: CELL ISOLATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 227 EUROPE: CELL ISOLATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 228 ASIA PACIFIC: CELL ISOLATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 229 LATIN AMERICA: CELL ISOLATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 230 MIDDLE EAST: CELL ISOLATION MARKET FOR OTHER APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
TABLE 231 GCC COUNTRIES: CELL ISOLATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 232 CELL ISOLATION MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 233 CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION)
TABLE 234 NORTH AMERICA: CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 235 EUROPE: CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 236 ASIA PACIFIC: CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 237 LATIN AMERICA: CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 238 MIDDLE EAST: CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION)
TABLE 239 GCC COUNTRIES: CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 240 CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION)
TABLE 241 NORTH AMERICA: CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 242 EUROPE: CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 243 ASIA PACIFIC: CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 244 LATIN AMERICA: CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 245 MIDDLE EAST: CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION)
TABLE 246 GCC COUNTRIES: CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 247 CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2022-2029 (USD MILLION)
TABLE 248 NORTH AMERICA: CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 249 EUROPE: CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 250 ASIA PACIFIC: CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 251 LATIN AMERICA: CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 252 MIDDLE EAST: CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2022-2029 (USD MILLION)
TABLE 253 GCC COUNTRIES: CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 254 CELL ISOLATION MARKET FOR OTHER END USERS, BY REGION, 2022-2029 (USD MILLION)
TABLE 255 NORTH AMERICA: CELL ISOLATION MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 256 EUROPE: CELL ISOLATION MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 257 ASIA PACIFIC: CELL ISOLATION MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 258 LATIN AMERICA: CELL ISOLATION MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 259 MIDDLE EAST: CELL ISOLATION MARKET FOR OTHER END USERS, BY REGION, 2022-2029 (USD MILLION)
TABLE 260 GCC COUNTRIES: CELL ISOLATION MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 261 CELL ISOLATION MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 262 NORTH AMERICA: CELL ISOLATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 263 NORTH AMERICA: CELL ISOLATION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
TABLE 264 NORTH AMERICA: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 265 NORTH AMERICA: CELL ISOLATION MARKET FOR BEADS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 266 NORTH AMERICA: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 267 NORTH AMERICA: CELL ISOLATION MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
TABLE 268 NORTH AMERICA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 269 NORTH AMERICA: CELL ISOLATION MARKET, BY CELL SOURCE, 2022-2029 (USD MILLION)
TABLE 270 NORTH AMERICA: CELL ISOLATION MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
TABLE 271 NORTH AMERICA: CELL ISOLATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 272 NORTH AMERICA: CELL ISOLATION MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 273 US: CELL ISOLATION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
TABLE 274 US: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 275 US: CELL ISOLATION MARKET FOR BEADS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 276 US: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 277 US: CELL ISOLATION MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
TABLE 278 US: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 279 US: CELL ISOLATION MARKET, BY CELL SOURCE, 2022-2029 (USD MILLION)
TABLE 280 US: CELL ISOLATION MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
TABLE 281 US: CELL ISOLATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 282 US: CELL ISOLATION MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 283 CANADA: CELL ISOLATION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
TABLE 284 CANADA: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 285 CANADA: CELL ISOLATION MARKET FOR BEADS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 286 CANADA: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 287 CANADA: CELL ISOLATION MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
TABLE 288 CANADA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 289 CANADA: CELL ISOLATION MARKET, BY CELL SOURCE, 2022-2029 (USD MILLION)
TABLE 290 CANADA: CELL ISOLATION MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
TABLE 291 CANADA: CELL ISOLATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 292 CANADA: CELL ISOLATION MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 293 EUROPE: CELL ISOLATION MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 294 EUROPE: CELL ISOLATION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
TABLE 295 EUROPE: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 296 EUROPE: CELL ISOLATION MARKET FOR BEADS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 297 EUROPE: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 298 EUROPE: CELL ISOLATION MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
TABLE 299 EUROPE: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 300 EUROPE: CELL ISOLATION MARKET, BY CELL SOURCE, 2022-2029 (USD MILLION)
TABLE 301 EUROPE: CELL ISOLATION MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
TABLE 302 EUROPE: CELL ISOLATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 303 EUROPE: CELL ISOLATION MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 304 GERMANY: CELL ISOLATION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
TABLE 305 GERMANY: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 306 GERMANY: CELL ISOLATION MARKET FOR BEADS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 307 GERMANY: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 308 GERMANY: CELL ISOLATION MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
TABLE 309 GERMANY: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 310 GERMANY: CELL ISOLATION MARKET, BY CELL SOURCE, 2022-2029 (USD MILLION)
TABLE 311 GERMANY: CELL ISOLATION MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
TABLE 312 GERMANY: CELL ISOLATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 313 GERMANY: CELL ISOLATION MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 314 UK: CELL ISOLATION MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
TABLE 315 UK: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 316 UK: CELL ISOLATION MARKET FOR BEADS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 317 UK: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 318 UK: CELL ISOLATION MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
TABLE 319 UK: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 320 UK: CELL ISOLATION MARKET, BY CELL SOURCE, 2022-2029 (USD MILLION)
TABLE 321 UK: CELL ISOLATION MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
TABLE 322 UK: CELL ISOLATION MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 323 UK: CELL ISOLATION MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 324 FRANCE: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 325 FRANCE: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 326 FRANCE: CELL ISOLATION MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 327 FRANCE: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 328 FRANCE: CELL ISOLATION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 329 FRANCE: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 330 FRANCE: CELL ISOLATION MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
TABLE 331 FRANCE: CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 332 FRANCE: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 333 FRANCE: CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 334 ITALY: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 335 ITALY: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 336 ITALY: CELL ISOLATION MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 337 ITALY: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 338 ITALY: CELL ISOLATION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 339 ITALY: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 340 ITALY: CELL ISOLATION MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
TABLE 341 ITALY: CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 342 ITALY: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 343 ITALY: CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 344 SPAIN: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 345 SPAIN: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 346 SPAIN: CELL ISOLATION MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 347 SPAIN: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 348 SPAIN: CELL ISOLATION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 349 SPAIN: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 350 SPAIN: CELL ISOLATION MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
TABLE 351 SPAIN: CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 352 SPAIN: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 353 SPAIN: CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 354 REST OF EUROPE: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 355 REST OF EUROPE: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 356 REST OF EUROPE: CELL ISOLATION MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 357 REST OF EUROPE: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 358 REST OF EUROPE: CELL ISOLATION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 359 REST OF EUROPE: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 360 REST OF EUROPE: CELL ISOLATION MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
TABLE 361 REST OF EUROPE: CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 362 REST OF EUROPE: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 363 REST OF EUROPE: CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 364 ASIA PACIFIC: CELL ISOLATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 365 ASIA PACIFIC: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 366 ASIA PACIFIC: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 367 ASIA PACIFIC: CELL ISOLATION MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 368 ASIA PACIFIC: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 369 ASIA PACIFIC: CELL ISOLATION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 370 ASIA PACIFIC: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE,2022–2029 (USD MILLION)
TABLE 371 ASIA PACIFIC: CELL ISOLATION MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
TABLE 372 ASIA PACIFIC: CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 373 ASIA PACIFIC: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 374 ASIA PACIFIC: CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 375 CHINA: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 376 CHINA: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 377 CHINA: CELL ISOLATION MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 378 CHINA: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 379 CHINA: CELL ISOLATION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 380 CHINA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 381 CHINA: CELL ISOLATION MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
TABLE 382 CHINA: CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 383 CHINA: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 384 CHINA: CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 385 JAPAN: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 386 JAPAN: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 387 JAPAN: CELL ISOLATION MARKET FOR BEADS, BY TYPE,2022–2029 (USD MILLION)
TABLE 388 JAPAN: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 389 JAPAN: CELL ISOLATION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 390 JAPAN: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE,2022–2029 (USD MILLION)
TABLE 391 JAPAN: CELL ISOLATION MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
TABLE 392 JAPAN: CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 393 JAPAN: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 394 JAPAN: CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 395 INDIA: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 396 INDIA: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 397 INDIA: CELL ISOLATION MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 398 INDIA: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 399 INDIA: CELL ISOLATION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 400 INDIA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 401 INDIA: CELL ISOLATION MARKET, BY CELL SOURCE, .2022–2029 (USD MILLION)
TABLE 402 INDIA: CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 403 INDIA: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 404 INDIA: CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 405 AUSTRALIA: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 406 AUSTRALIA: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 407 AUSTRALIA: CELL ISOLATION MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 408 AUSTRALIA: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 409 AUSTRALIA: CELL ISOLATION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 410 AUSTRALIA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 411 AUSTRALIA: CELL ISOLATION MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
TABLE 412 AUSTRALIA: CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 413 AUSTRALIA: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 414 AUSTRALIA: CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 415 SOUTH KOREA: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 416 SOUTH KOREA: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 417 SOUTH KOREA: CELL ISOLATION MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 418 SOUTH KOREA: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 419 SOUTH KOREA: CELL ISOLATION MARKET, BY CELL TYPE,2022–2029 (USD MILLION)
TABLE 420 SOUTH KOREA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 421 SOUTH KOREA: CELL ISOLATION MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
TABLE 422 SOUTH KOREA: CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 423 SOUTH KOREA: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 424 SOUTH KOREA: CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 425 REST OF ASIA PACIFIC: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 426 REST OF ASIA PACIFIC: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 427 REST OF ASIA PACIFIC: CELL ISOLATION MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 428 REST OF ASIA PACIFIC: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 429 REST OF ASIA PACIFIC: CELL ISOLATION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 430 REST OF ASIA PACIFIC: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 431 REST OF ASIA PACIFIC: CELL ISOLATION MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
TABLE 432 REST OF ASIA PACIFIC: CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 433 REST OF ASIA PACIFIC: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 434 REST OF ASIA PACIFIC: CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 435 LATIN AMERICA: CELL ISOLATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 436 LATIN AMERICA: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 437 LATIN AMERICA: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 438 LATIN AMERICA: CELL ISOLATION MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 439 LATIN AMERICA: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 440 LATIN AMERICA: CELL ISOLATION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 441 LATIN AMERICA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 442 LATIN AMERICA: CELL ISOLATION MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
TABLE 443 LATIN AMERICA: CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 444 LATIN AMERICA: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 445 LATIN AMERICA: CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 446 BRAZIL: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 447 BRAZIL: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 448 BRAZIL: CELL ISOLATION MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 449 BRAZIL: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 450 BRAZIL: CELL ISOLATION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 451 BRAZIL: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 452 BRAZIL: CELL ISOLATION MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
TABLE 453 BRAZIL: CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 454 BRAZIL: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 455 BRAZIL: CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 456 MEXICO: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 457 MEXICO: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 458 MEXICO: CELL ISOLATION MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 459 MEXICO: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 460 MEXICO: CELL ISOLATION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 461 MEXICO: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 462 MEXICO: CELL ISOLATION MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
TABLE 463 MEXICO: CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 464 MEXICO: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 465 MEXICO: CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 466 REST OF LATIN AMERICA: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 467 REST OF LATIN AMERICA: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 468 REST OF LATIN AMERICA: CELL ISOLATION MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 469 REST OF LATIN AMERICA: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 470 REST OF LATIN AMERICA: CELL ISOLATION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 471 REST OF LATIN AMERICA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 472 REST OF LATIN AMERICA: CELL ISOLATION MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
TABLE 473 REST OF LATIN AMERICA: CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 474 REST OF LATIN AMERICA: CELL ISOLATION MARKET, BY APPLICATION,2022–2029 (USD MILLION)
TABLE 475 REST OF LATIN AMERICA: CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 476 MIDDLE EAST: CELL ISOLATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 477 MIDDLE EAST: CELL ISOLATION MARKET, BY PRODUCT,2022–2029 (USD MILLION)
TABLE 478 MIDDLE EAST: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 479 MIDDLE EAST: CELL ISOLATION MARKET FOR BEADS, BY TYPE,2022–2029 (USD MILLION)
TABLE 480 MIDDLE EAST: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 481 MIDDLE EAST: CELL ISOLATION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 482 MIDDLE EAST: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 483 MIDDLE EAST: CELL ISOLATION MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
TABLE 484 MIDDLE EAST: CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 485 MIDDLE EAST: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 486 MIDDLE EAST: CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 487 GCC: CELL ISOLATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 488 GCC: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 489 GCC: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 490 GCC: CELL ISOLATION MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 491 GCC: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 492 GCC: CELL ISOLATION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 493 GCC: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 494 GCC: CELL ISOLATION MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
TABLE 495 GCC: CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 496 GCC: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 497 GCC: CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 498 SAUDI ARABIA: CELL ISOLATION MARKET, BY PRODUCT, >2022–2029 (USD MILLION)
TABLE 499 SAUDI ARABIA: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 500 SAUDI ARABIA: CELL ISOLATION MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 501 SAUDI ARABIA: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 502 SAUDI ARABIA: CELL ISOLATION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 503 SAUDI ARABIA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 504 SAUDI ARABIA: CELL ISOLATION MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
TABLE 505 SAUDI ARABIA: CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 506 SAUDI ARABIA: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 507 SAUDI ARABIA: CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 508 UAE: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 509 UAE: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 510 UAE: CELL ISOLATION MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 511 UAE: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 512 UAE: CELL ISOLATION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 513 UAE: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 514 UAE: CELL ISOLATION MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
TABLE 515 UAE: CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 516 UAE: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 517 UAE: CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 518 REST OF GCC COUNTRIES: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 519 REST OF GCC COUNTRIES: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 520 REST OF GCC COUNTRIES: CELL ISOLATION MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 521 REST OF GCC COUNTRIES: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 522 REST OF GCC COUNTRIES: CELL ISOLATION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 523 REST OF GCC COUNTRIES: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 524 REST OF GCC COUNTRIES: CELL ISOLATION MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
TABLE 525 REST OF GCC COUNTRIES: CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 526 REST OF GCC COUNTRIES: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 527 REST OF GCC COUNTRIES: CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 528 REST OF MIDDLE EAST: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 529 REST OF MIDDLE EAST: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 530 REST OF MIDDLE EAST: CELL ISOLATION MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 531 REST OF MIDDLE EAST: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 532 REST OF MIDDLE EAST: CELL ISOLATION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 533 REST OF MIDDLE EAST: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 534 REST OF MIDDLE EAST: CELL ISOLATION MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
TABLE 535 REST OF MIDDLE EAST: CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 536 REST OF MIDDLE EAST: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 537 REST OF MIDDLE EAST: CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 538 AFRICA: CELL ISOLATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 539 AFRICA: CELL ISOLATION MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 540 AFRICA: CELL ISOLATION MARKET FOR BEADS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 541 AFRICA: CELL ISOLATION MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 542 AFRICA: CELL ISOLATION MARKET, BY CELL TYPE, 2022–2029 (USD MILLION)
TABLE 543 AFRICA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 544 AFRICA: CELL ISOLATION MARKET, BY CELL SOURCE, 2022–2029 (USD MILLION)
TABLE 545 AFRICA: CELL ISOLATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)
TABLE 546 AFRICA: CELL ISOLATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 547 AFRICA: CELL ISOLATION MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 548 OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES
TABLE 549 CELL ISOLATION MARKET: DEGREE OF COMPETITION
TABLE 550 CELL ISOLATION MARKET: REGION FOOTPRINT
TABLE 551 CELL ISOLATION MARKET: PRODUCT FOOTPRINT
TABLE 552 CELL ISOLATION MARKET: CELL TYPE FOOTPRINT
TABLE 553 CELL ISOLATION MARKET: END USER FOOTPRINT
TABLE 554 CELL ISOLATION MARKET: DETAILED LIST OF KEY STARTUPS/SMES
TABLE 555 CELL ISOLATION MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
TABLE 556 CELL ISOLATION MARKET: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2024
TABLE 557 CELL ISOLATION MARKET: DEALS, JANUARY 2021–JUNE 2024
TABLE 558 CELL ISOLATION MARKET: EXPANSIONS, JANUARY 2021–JUNE 2024
TABLE 559 CELL ISOLATION MARKET: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2024
TABLE 560 DANAHER CORPORATION: COMPANY OVERVIEW
TABLE 561 DANAHER CORPORATION: PRODUCTS OFFERED
TABLE 562 DANAHER CORPORATION: DEALS, JANUARY 2021–JUNE 2024
TABLE 563 MERCK KGAA: COMPANY OVERVIEW
TABLE 564 MERCK KGAA: PRODUCTS OFFERED
TABLE 565 MERCK KGAA: DEALS, JANUARY 2021–JUNE 2024
TABLE 566 MERCK KGAA: EXPANSIONS, JANUARY 2021–JUNE 2024
TABLE 567 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
TABLE 568 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
TABLE 569 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2024
TABLE 570 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021–JUNE 2024
TABLE 571 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2021–JUNE 2024
TABLE 572 BD: COMPANY OVERVIEW
TABLE 573 BD: PRODUCTS OFFERED
TABLE 574 BD: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2024
TABLE 575 BD: DEALS, JANUARY 2021–JUNE 2024
TABLE 576 BD: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2024
TABLE 577 SARTORIUS AG: COMPANY OVERVIEW
TABLE 578 SARTORIUS AG: PRODUCTS OFFERED
TABLE 579 SARTORIUS AG: DEALS, JANUARY 2021–JUNE 2024
TABLE 580 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
TABLE 581 AGILENT TECHNOLOGIES, INC.: PRODUCTS OFFERED
TABLE 582 AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2021–JUNE 2024
TABLE 583 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
TABLE 584 BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED
TABLE 585 BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2024
TABLE 586 QIAGEN: COMPANY OVERVIEW
TABLE 587 QIAGEN: PRODUCTS OFFERED
TABLE 588 QIAGEN: DEALS, JANUARY 2021–JUNE 2024
TABLE 589 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW
TABLE 590 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS OFFERED
TABLE 591 REVVITY: COMPANY OVERVIEW
TABLE 592 REVVITY: PRODUCTS OFFERED
TABLE 593 REVVITY: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2024
TABLE 594 CORNING INCORPORATED: COMPANY OVERVIEW
TABLE 595 CORNING INCORPORATED: PRODUCTS OFFERED
TABLE 596 LONZA: COMPANY OVERVIEW
TABLE 597 LONZA: PRODUCTS OFFERED
TABLE 598 LONZA: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2024
TABLE 599 LONZA: DEALS, JANUARY 2021–JUNE 2024
TABLE 600 BIO-TECHNE: COMPANY OVERVIEW
TABLE 601 BIO-TECHNE: PRODUCTS OFFERED
TABLE 602 BIO-TECHNE: DEALS, JANUARY 2021–JUNE 2024
TABLE 603 BIO-TECHNE: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2024
TABLE 604 TERUMO CORPORATION: COMPANY OVERVIEW
TABLE 605 TERUMO CORPORATION: PRODUCTS OFFERED
TABLE 606 TERUMO CORPORATION: DEALS, JANUARY 2021–JUNE 2024
TABLE 607 MILTENYI BIOTEC: COMPANY OVERVIEW
TABLE 608 MILTENYI BIOTEC: PRODUCTS OFFERED
TABLE 609 TAKARA BIO INC.: COMPANY OVERVIEW
TABLE 610 TAKARA BIO INC.: PRODUCTS OFFERED
TABLE 611 TAKARA BIO INC.: DEALS, JANUARY 2021–JUNE 2024
TABLE 612 GENSCRIPT: COMPANY OVERVIEW
TABLE 613 GENSCRIPT: PRODUCTS OFFERED
TABLE 614 GENSCRIPT: DEALS, JANUARY 2021–JUNE 2024
TABLE 615 STANDARD BIOTOOLS: COMPANY OVERVIEW
TABLE 616 STANDARD BIOTOOLS: PRODUCTS OFFERED
TABLE 617 ALFA LAVAL: COMPANY OVERVIEW
TABLE 618 ALFA LAVAL: PRODUCTS OFFERED
TABLE 619 ALFA LAVAL: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2024
TABLE 620 ALFA LAVAL: DEALS, JANUARY 2021–JUNE 2024
TABLE 621 PROMEGA CORPORATION: COMPANY OVERVIEW
TABLE 622 CELL SIGNALING TECHNOLOGY, INC.: COMPANY OVERVIEW
TABLE 623 MICAREO INC.: COMPANY OVERVIEW
TABLE 624 APPLIED CELLS INC.: COMPANY OVERVIEW
TABLE 625 STEMCELL TECHNOLOGIES: COMPANY OVERVIEW
TABLE 626 CREATIVE BIOARRAY: COMPANY OVERVIEW
TABLE 627 PROTEINTECH GROUP, INC.: COMPANY OVERVIEW
TABLE 628 MAGBIO GENOMICS, INC.: COMPANY OVERVIEW
TABLE 629 AKADEUM LIFE SCIENCES: COMPANY OVERVIEW
TABLE 630 PLURISELECT LIFE SCIENCE UG (HAFTUNGSBESCHRÄNKT) & CO. KG: COMPANY OVERVIEW
TABLE 631 INVENT BIOTECHNOLOGIES, INC.: COMPANY OVERVIEW

List of Figures

FIGURE 1 CELL ISOLATION MARKET SEGMENTATION
FIGURE 2 RESEARCH DESIGN
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS
FIGURE 4 MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023
FIGURE 5 MARKET SIZE ESTIMATION: COMPANY REVENUE ANALYSIS-BASED ESTIMATION, 2023
FIGURE 6 ILLUSTRATIVE EXAMPLE OF DANAHER CORPORATION: REVENUE SHARE ANALYSIS, 2023
FIGURE 7 INSIGHTS FROM PRIMARY SOURCES
FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
FIGURE 9 CELL ISOLATION MARKET: CAGR PROJECTIONS
FIGURE 10 DATA TRIANGULATION
FIGURE 11 CELL ISOLATION MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
FIGURE 12 CELL ISOLATION MARKET, BY CELL TYPE, 2024 VS. 2029 (USD MILLION)
FIGURE 13 CELL ISOLATION MARKET, BY CELL SOURCE, 2024 VS. 2029 (USD MILLION)
FIGURE 14 CELL ISOLATION MARKET, BY TECHNIQUE, 2024 VS. 2029 (USD MILLION)
FIGURE 15 CELL ISOLATION MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
FIGURE 16 CELL ISOLATION MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
FIGURE 17 GEOGRAPHICAL SNAPSHOT OF CELL ISOLATION MARKET
FIGURE 18 INCREASING GOVERNMENT FUNDING FOR CELL-BASED RESEARCH AND GROWING FOCUS ON PERSONALIZED MEDICINE TO DRIVE MARKET
FIGURE 19 CONSUMABLES SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN CELL ISOLATION MARKET IN 2023
FIGURE 20 BIOMOLECULE ISOLATION SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
FIGURE 21 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT DOMINATED MARKET IN 2023
FIGURE 22 ASIA PACIFIC COUNTRIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD
FIGURE 23 CELL ISOLATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 24 GLOBAL HIV EPIDEMIC, 2022
FIGURE 25 REVENUE SHIFT AND NEW REVENUE POCKETS
FIGURE 26 AVERAGE SELLING PRICE TREND OF PRODUCTS, BY TECHNIQUE, 2021-2023 (USD)
FIGURE 27 VALUE CHAIN ANALYSIS
FIGURE 28 PATENT ANALYSIS, 2014-2024
FIGURE 29 SUPPLY CHAIN ANALYSIS
FIGURE 30 ECOSYSTEM ANALYSIS
FIGURE 31 PORTER'S FIVE FORCES
FIGURE 32 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS
FIGURE 33 BUYING CRITERIA, BY END USER
FIGURE 34 FLUORESCENCE-ACTIVATED CELL SORTERS MARKET, 2022-2029 (UNITS)
FIGURE 35 NORTH AMERICA: CELL ISOLATION MARKET SNAPSHOT
FIGURE 36 ASIA PACIFIC: CELL ISOLATION MARKET SNAPSHOT
FIGURE 37 REVENUE ANALYSIS OF TOP 4 PLAYERS, 2021-2023 (USD MILLION)
FIGURE 38 MARKET SHARE ANALYSIS, 2023
FIGURE 39 CELL ISOLATION MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
FIGURE 40 CELL ISOLATION MARKET: COMPANY FOOTPRINT
FIGURE 41 CELL ISOLATION MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
FIGURE 42 COMPANY VALUATION
FIGURE 43 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 44 CELL ISOLATION MARKET: BRAND/PRODUCT COMPARISON
FIGURE 45 DANAHER CORPORATION: COMPANY SNAPSHOT (2023)
FIGURE 46 MERCK KGAA: COMPANY SNAPSHOT (2023)
FIGURE 47 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023)
FIGURE 48 BD: COMPANY SNAPSHOT (2023)
FIGURE 49 SARTORIUS AG: COMPANY SNAPSHOT (2023)
FIGURE 50 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2023)
FIGURE 51 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2023)
FIGURE 52 QIAGEN: COMPANY SNAPSHOT (2023)
FIGURE 53 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2023)
FIGURE 54 REVVITY: COMPANY SNAPSHOT (2023)
FIGURE 55 CORNING INCORPORATED: COMPANY SNAPSHOT (2023)
FIGURE 56 LONZA: COMPANY SNAPSHOT (2023)
FIGURE 57 BIO-TECHNE: COMPANY SNAPSHOT (2023)
FIGURE 58 TERUMO CORPORATION: COMPANY SNAPSHOT (2023)
FIGURE 59 TAKARA BIO INC.: COMPANY SNAPSHOT (2023)
FIGURE 60 GENSCRIPT: COMPANY SNAPSHOT (2023)
FIGURE 61 STANDARD BIOTOOLS: COMPANY SNAPSHOT (2023)
FIGURE 62 ALFA LAVAL: COMPANY SNAPSHOT (2023)